Akathisia in Post Operative Outpatients Surgery
NCT01942343
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Akathisia
Interventions
DRUG:
Droperidol 1,25 mg administration, Droperidol 0,625 mg administration, Odansetron 4 mg administration
Sponsor
University Hospital, Strasbourg, France